Jennifer Doan

Array ( [id] => 285548 [patent_doc_number] => 07550475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Condensed polycyclic compounds' [patent_app_type] => utility [patent_app_number] => 11/515907 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9295 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550475.pdf [firstpage_image] =>[orig_patent_app_number] => 11515907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285537 [patent_doc_number] => 07550464 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Condensed polycyclic compounds' [patent_app_type] => utility [patent_app_number] => 11/515737 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9298 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550464.pdf [firstpage_image] =>[orig_patent_app_number] => 11515737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 352705 [patent_doc_number] => 07491727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-17 [patent_title] => 'Arylpiperazinyl compounds' [patent_app_type] => utility [patent_app_number] => 11/516345 [patent_app_country] => US [patent_app_date] => 2006-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29521 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/491/07491727.pdf [firstpage_image] =>[orig_patent_app_number] => 11516345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 247111 [patent_doc_number] => 07585863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Therapeutic amides' [patent_app_type] => utility [patent_app_number] => 11/469205 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17415 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585863.pdf [firstpage_image] =>[orig_patent_app_number] => 11469205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977707 [patent_doc_number] => 08071600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disorders' [patent_app_type] => utility [patent_app_number] => 11/991146 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112808 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071600.pdf [firstpage_image] =>[orig_patent_app_number] => 11991146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676932 [patent_doc_number] => 20080214563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Benzimidazole Thiophene Compounds As Plk Modulators' [patent_app_type] => utility [patent_app_number] => 12/065684 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19261 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214563.pdf [firstpage_image] =>[orig_patent_app_number] => 12065684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 236349 [patent_doc_number] => 07595330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Benzimidazole thiophene compounds' [patent_app_type] => utility [patent_app_number] => 11/467577 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26994 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595330.pdf [firstpage_image] =>[orig_patent_app_number] => 11467577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676936 [patent_doc_number] => 20080214567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Benzimidazole Thiophene Compounds' [patent_app_type] => utility [patent_app_number] => 12/065668 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26957 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214567.pdf [firstpage_image] =>[orig_patent_app_number] => 12065668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292395 [patent_doc_number] => 07544686 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof' [patent_app_type] => utility [patent_app_number] => 11/509769 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18295 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544686.pdf [firstpage_image] =>[orig_patent_app_number] => 11509769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688995 [patent_doc_number] => 20060287310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => '[1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA' [patent_app_type] => utility [patent_app_number] => 11/466828 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 142847 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287310.pdf [firstpage_image] =>[orig_patent_app_number] => 11466828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5688994 [patent_doc_number] => 20060287309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => '[1,8]NAPHTHYRIDIN-2-ONES AND RELATED COMPOUNDS FOR THE TREATMENT OF SCHIZOPHRENIA' [patent_app_type] => utility [patent_app_number] => 11/466822 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 142864 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287309.pdf [firstpage_image] =>[orig_patent_app_number] => 11466822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4576035 [patent_doc_number] => 07855290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-21 [patent_title] => 'Pyridine derivatives and pyrimidine derivatives (3)' [patent_app_type] => utility [patent_app_number] => 11/508322 [patent_app_country] => US [patent_app_date] => 2006-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 91109 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/855/07855290.pdf [firstpage_image] =>[orig_patent_app_number] => 11508322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800414 [patent_doc_number] => 07425558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Serotonergic agents for treating sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 11/506514 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 7834 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425558.pdf [firstpage_image] =>[orig_patent_app_number] => 11506514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000425 [patent_doc_number] => 20070043059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'N-oxides as prodrugs of piperazine and piperidine derivatives' [patent_app_type] => utility [patent_app_number] => 11/504050 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6972 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043059.pdf [firstpage_image] =>[orig_patent_app_number] => 11504050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292394 [patent_doc_number] => 07544685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => '2,3-dihydroindole compounds' [patent_app_type] => utility [patent_app_number] => 11/504186 [patent_app_country] => US [patent_app_date] => 2006-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14766 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544685.pdf [firstpage_image] =>[orig_patent_app_number] => 11504186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32838 [patent_doc_number] => 07790726 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Monocyclic and bicyclic compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/504215 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 41473 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790726.pdf [firstpage_image] =>[orig_patent_app_number] => 11504215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149518 [patent_doc_number] => 20070049578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Cinnamamide compounds as metabotropic glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/503182 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20078 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049578.pdf [firstpage_image] =>[orig_patent_app_number] => 11503182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5155091 [patent_doc_number] => 20070037974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Inhibitors of P2X3' [patent_app_type] => utility [patent_app_number] => 11/502797 [patent_app_country] => US [patent_app_date] => 2006-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26929 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037974.pdf [firstpage_image] =>[orig_patent_app_number] => 11502797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760020 [patent_doc_number] => 20080312246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Substituted Piperazines as Metabotropic Glutamate Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/997444 [patent_app_country] => US [patent_app_date] => 2006-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16570 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312246.pdf [firstpage_image] =>[orig_patent_app_number] => 11997444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5154937 [patent_doc_number] => 20070037820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Substituted piperazines as metabotropic glutamate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/498835 [patent_app_country] => US [patent_app_date] => 2006-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16591 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037820.pdf [firstpage_image] =>[orig_patent_app_number] => 11498835 [rel_patent_id] =>[rel_patent_doc_number] =>)